Exogenous Creatinine Assay Kit can measure creatinine levels in urine, serum, and culture media samples. This test is done to see how well your kidneys are working. Creatinine can also be measured with a urine test. A measurement of the serum creatinine level is often used to evaluate kidney function.
The global market for Exogenous Creatinine Assay Kit is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Exogenous Creatinine Assay Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Exogenous Creatinine Assay Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Exogenous Creatinine Assay Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Exogenous Creatinine Assay Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Exogenous Creatinine Assay Kit players cover Roche, Siemens Healthineers, Abbott, Leadman Biochemis and Kanto Chemica, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Exogenous Creatinine Assay Kit market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Exogenous Creatinine Assay Kit market, with both quantitative and qualitative data, to help readers understand how the Exogenous Creatinine Assay Kit market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Exogenous Creatinine Assay Kit market and forecasts the market size by Type (Jaffe's Kinetic Method and Enzymatic Method,), by Application (Hospital and Laboratories.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Jaffe's Kinetic Method
Enzymatic Method
Segmentation by application
Hospital
Laboratories
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Roche
Siemens Healthineers
Abbott
Leadman Biochemis
Kanto Chemica
Chondrex
Beijing Leadman Biochemistry
Maccura Biotechnology
Shenzhen Goldsite Diagnostics
Beijing Solarbio Science & Technology
Beijing Strong Biotechnologies
Ningbo Ruiyuan Biotechnology
Shanghai Fosun Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Exogenous Creatinine Assay Kit, Research Methodology, etc.
Chapter 2: Executive Summary, global Exogenous Creatinine Assay Kit market size (sales and revenue) and CAGR, Exogenous Creatinine Assay Kit market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Exogenous Creatinine Assay Kit sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Exogenous Creatinine Assay Kit sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Exogenous Creatinine Assay Kit market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Roche, Siemens Healthineers, Abbott, Leadman Biochemis, Kanto Chemica, Chondrex, Beijing Leadman Biochemistry, Maccura Biotechnology and Shenzhen Goldsite Diagnostics, etc.
Chapter 14: Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Exogenous Creatinine Assay Kit. Industry analysis & Market Report on Exogenous Creatinine Assay Kit is a syndicated market report, published as Global Exogenous Creatinine Assay Kit Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Exogenous Creatinine Assay Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.